Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YCCEL1 |
Human gastric carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | virusproduction | Metafectene | publication | M.-H. Tsai et al., Oncotarget, 2017, 8 (6): 10238-10254 | Link | ||
Y-79 |
Human retinablastoma cell line | ATCC HTB-18 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Gao et al., Inc. J. Biochem. Mol. Toxicol., 2014, 28 :394-399, DOI 10.1002/jbt.21576 | ||
Y-79 |
Human retinablastoma cell line | ATCC HTB-18 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Gao et al., Mol. Cell Biochem., 2016, 414:77-84; DOI 10.1007/s11010-016-2660-y | ||
WS-15 |
Human breast cancer cell line | Human | breast | cell line | plasmid | RNA-Interference | Metafectene | publication | M. P.V. Shekhar et al., Cancer Res., Mar 2008; 68: 1741 - 1750 | Link | |||
WiDr |
Human colorectal adenocarcinoma cell line | ATCC CCL-218 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | P. Suboj et al., Pharmacology, 2012, 89: 91–98, DOI: 10.1159/000335659 | ||
WI-38 |
Human lung fibroblast cells | ATCC CCL-75 | Human | respiratory system | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
WI-38 |
Human lung fibroblast cells | ATCC CCL-75 | Human | respiratory system | unknown | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
WI-38 |
Human lung fibroblast cells | ATCC CCL-75 | Human | respiratory system | unknown | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
WERI-Rb1 |
Human retinoblastoma cell line | ATCC HBT-169 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Liang et al., Experimantal and Therapeutic Medicine, 2017, 14: 2367-2372, DOI: 10.3892/etm.2017.4779 | Link | |
WERI-Rb1 |
Human retinoblastoma cell line | ATCC HBT-169 | Human | sensory organs | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | Y. Liu et al., Pathology - Res. and Practice, 2019, 215, 152641, doi.org/10.1016/j.prp.2019.152641 | Link | |
UACC-257 |
Human melanoma cells | Human | skin | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Vamanet al., 2015, PLoS ONE 10(6): e0129219; doi:10.1371/journal.pone.0129219 | Link | ||
U937 |
Human histiocytic lymphoma cell line | ATCC CRL-1593.2 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Kim et al., Innate Immunity, Nov 2014; 20: 799 - 815. | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | B. Li et al., ResearchSquare, 2020, doi.org/10.21203/rs.3.rs-58864/v1 | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | Y. Tomioka et al., J. Gen. Virol., Mar 2004; 85: 647 - 652 | Link | ||
U87 MG |
Human brain glioblastoma cell line | ATCC HTB-14 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
U343 |
Human malignant astrocytoma cell line | Human | brain | cell line | plasmid | Metafectene | publication | V. Voss et al., Mol. Cancer Res., Jul 2010; 8: 1002 - 1016 | Link | ||||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | M. Lang-Muritano et al., J. of Clinical Endocrinology & Metabolism, 2018, 103(10): 3748–3756 | |||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | T. I. Sheikh et al., Translat. Psychiatry, 2021,1 1:1, doi.org/10.1038/s41398-020-01158-w | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | R. X. Xu et al., Nan Fang Yi Ke Da Xue Xue Bao, Apr 2006; 26(4): 398-401 | |||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Hagemann et al., Neuro Oncology, Dec 2013; 15: 1696 - 1709 | Link | ||
U138 MG |
Human brain glioblastoma cell line | ATCC HTB-16 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Hagemann et al., Neuro Oncology, Dec 2013; 15: 1696 - 1709 | Link | |
U-2 OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | T. Dietschy et al., J. Cell Sci., Apr 2009; 122: 1258 - 1267 | Link | ||
U-2 OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. Zheng et al., Nucleic Acids Res., May 2009; 37: 2645 - 2657 | Link | |
TT |
Human medullary thyroid carcinoma cell line | ATCC CRL-1803 | Human | other | cell line | adherent | plasmid | Metafectene | publication | T. Takahashi et al., J. Biochem., Nov 2009; 146: 675 - 682 | |||
tsA201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | Metafectene | application note | ![]() |